News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,400 Results
Type
Article (2593)
Company Profile (43)
Press Release (37763)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14204)
Career Advice (78)
Deals (2111)
Drug Delivery (9)
Drug Development (4149)
Employer Resources (10)
FDA (444)
Job Trends (784)
News (20295)
Policy (1057)
Tag
Academia (146)
Allergies (7)
Alliances (3491)
ALS (6)
Alzheimer's disease (62)
Antibody-drug conjugate (ADC) (35)
Approvals (447)
Artificial intelligence (34)
Autoimmune disease (13)
Automation (3)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (46)
Cancer (353)
Cardiovascular disease (12)
Career advice (66)
Career pathing (1)
CAR-T (33)
CDC (1)
Cell therapy (87)
Cervical cancer (3)
Clinical research (3482)
Collaboration (220)
Company closure (2)
Compensation (112)
COVID-19 (186)
CRISPR (12)
C-suite (120)
Cystic fibrosis (7)
Data (461)
Denatured (6)
Depression (12)
Diabetes (17)
Diagnostics (497)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (39)
Drug pricing (10)
Duchenne muscular dystrophy (50)
Earnings (4565)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6470)
Executive appointments (137)
FDA (602)
Friedreich's ataxia (6)
Frontotemporal dementia (1)
Funding (180)
Gene editing (36)
Generative AI (2)
Gene therapy (59)
GLP-1 (66)
Government (159)
Guidances (24)
Healthcare (708)
HIV (2)
Huntington's disease (6)
IgA nephropathy (12)
Immunology and inflammation (35)
Immuno-oncology (15)
Indications (8)
Infectious disease (201)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (8)
Intellectual property (32)
Interviews (7)
IPO (1002)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (7)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (4)
Lung cancer (33)
Lymphoma (13)
Machine learning (3)
Management (4)
Manufacturing (61)
MASH (16)
Medical device (316)
Medtech (318)
Mergers & acquisitions (1227)
Metabolic disorders (81)
mRNA (8)
Multiple sclerosis (25)
Neurodegenerative disease (34)
Neuropsychiatric disorders (11)
Neuroscience (180)
NextGen: Class of 2026 (353)
Non-profit (156)
Now hiring (12)
Obesity (37)
Opinion (17)
Ovarian cancer (19)
Pain (26)
Pancreatic cancer (23)
Parkinson's disease (14)
Partnered (4)
Patents (58)
Patient recruitment (38)
Peanut (1)
People (5903)
Pharmaceutical (3)
Phase 1 (1493)
Phase 2 (1724)
Phase 3 (925)
Pipeline (506)
Policy (17)
Postmarket research (30)
Preclinical (648)
Press Release (2)
Prostate cancer (7)
Psychedelics (4)
Radiopharmaceuticals (16)
Rare diseases (73)
Real estate (425)
Recruiting (5)
Regulatory (937)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (2)
Schizophrenia (16)
Series A (51)
Series B (22)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (498)
Stomach cancer (3)
Supply chain (6)
Tariffs (2)
The Weekly (3)
Vaccines (54)
Venture capital (15)
Weight loss (23)
Women's health (13)
Worklife (1)
Date
Today (8)
Last 7 days (36)
Last 30 days (205)
Last 365 days (2408)
2026 (511)
2025 (2438)
2024 (2609)
2023 (2858)
2022 (3755)
2021 (4052)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1798)
2016 (1625)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (45)
Alabama (3)
Arizona (18)
Asia (1962)
Australia (308)
California (1713)
Canada (262)
China (92)
Colorado (59)
Connecticut (17)
Delaware (7)
Europe (4050)
Florida (68)
Georgia (13)
Hawaii (2)
Idaho (3)
Illinois (22)
India (3)
Indiana (66)
Japan (18)
Kansas (14)
Kentucky (1)
Maryland (57)
Massachusetts (603)
Michigan (14)
Minnesota (23)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (141)
New York (86)
North Carolina (141)
Northern California (848)
Ohio (49)
Oklahoma (2)
Oregon (6)
Pennsylvania (120)
Puerto Rico (1)
Rhode Island (3)
South America (40)
South Carolina (2)
Southern California (696)
Tennessee (5)
Texas (163)
United States (3431)
Utah (5)
Virginia (12)
Washington D.C. (3)
Washington State (96)
West Virginia (1)
Wisconsin (14)
40,400 Results for "caladrius biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enveric Biosciences Announces Registration of Five Trademarks
March 18, 2026
·
4 min read
Press Releases
Aura Biosciences to Participate in Upcoming March 2026 Investor Conferences
February 25, 2026
·
1 min read
Press Releases
Allosteric Bioscience, Inc. Targets Extending Longevity
March 5, 2026
·
1 min read
Press Releases
Artelo Biosciences Announces Reverse Stock Split
March 6, 2026
·
4 min read
Press Releases
Marvel Biosciences Sponsors Scientific Meeting on Purines
March 4, 2026
·
4 min read
Press Releases
Genflow Biosciences PLC Announces Result of GM
March 2, 2026
·
2 min read
Press Releases
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
March 11, 2026
·
1 min read
Press Releases
Korsana Biosciences to Present at the Stifel 2026 Virtual CNS Forum
March 12, 2026
·
1 min read
Deals
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”) and Cend Therapeutics, Inc. (“Cend”) today announced that the proposed merger of the two companies has closed following the approval of Caladrius’ stockholders on September 13, 2022.
September 15, 2022
·
8 min read
Press Releases
MBX Biosciences Appoints Karen Basbaum as Chief Business Officer
March 10, 2026
·
5 min read
1 of 4,040
Next
